Revelation Biosciences (REVB) Earnings Date & Reports
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
REVB is expected to report earnings to rise 608.05% to -615 cents per share on November 05
Q3'26
Est.
$-6.16
Q2'26
Missed
by $0.04
Q4'25
Beat
by $8.25
Q3'25
Beat
by $7.83
Q2'25
Beat
by $1.99
The last earnings report on August 07 showed earnings per share of -87 cents, missing the estimate of -82 cents. With 24.34K shares outstanding, the current market capitalization sits at 14.46M.